Viewing StudyNCT06319170

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 8:16 PM
Last Modification Date: 2024-10-26 @ 3:24 PM
Study NCT ID: NCT06319170
Status: RECRUITING
Last Update Posted: 2024-06-12
First Post: 2024-03-13
Brief Title: Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With SchizophreniaSchizoaffective Disorder
Sponsor: Teva Branded Pharmaceutical Products RD Inc
Organization: Teva Branded Pharmaceutical Products RD Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Organization Data

Organization: Teva Branded Pharmaceutical Products RD Inc
Class: INDUSTRY
Study ID: TV44749-NPC-10205
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Teva Branded Pharmaceutical Products RD Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators